Previous close | 33.49 |
Open | 33.24 |
Bid | 29.00 x 800 |
Ask | 32.15 x 1400 |
Day's range | 30.07 - 33.37 |
52-week range | 15.58 - 78.58 |
Volume | |
Avg. volume | 313,579 |
Market cap | 844.923M |
Beta (5Y monthly) | 1.17 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.04 |
Earnings date | 07 Nov 2022 - 11 Nov 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 50.57 |
Castle Biosciences, Inc. ( NASDAQ:CSTL ) shareholders will have a reason to smile today, with the analysts making...
Castle Biosciences, Inc. (CSTL) delivered earnings and revenue surprises of 89.66% and 22.67%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
FRIENDSWOOD, Texas, August 08, 2022--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the second quarter and six months ended June 30, 2022.